167 related articles for article (PubMed ID: 36258158)
1. Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK.
Isitt JJ; Roze S; Sharland H; Cogswell G; Alshannaq H; Norman GJ; Lynch PM
Diabetes Ther; 2022 Dec; 13(11-12):1875-1890. PubMed ID: 36258158
[TBL] [Abstract][Full Text] [Related]
2. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia.
Isitt JJ; Roze S; Tilden D; Arora N; Palmer AJ; Jones T; Rentoul D; Lynch P
Diabet Med; 2022 Jul; 39(7):e14831. PubMed ID: 35298036
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
[No Abstract] [Full Text] [Related]
4. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada.
Alshannaq H; Isitt JJ; Pollock RF; Norman GJ; Cogswell G; Lynch PM; Roze S
J Comp Eff Res; 2023 Oct; 12(10):e230075. PubMed ID: 37668608
[No Abstract] [Full Text] [Related]
5. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
Roze S; Isitt JJ; Smith-Palmer J; Lynch P
Clinicoecon Outcomes Res; 2021; 13():717-725. PubMed ID: 34408456
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.
Alshannaq H; Cogswell G; Pollock RF; Ahmed W; Norman GJ; Lynch PM; Roze S
Diabetes Obes Metab; 2023 Sep; 25(9):2704-2713. PubMed ID: 37334522
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France.
Roze S; Isitt JJ; Smith-Palmer J; Lynch P; Klinkenbijl B; Zammit G; Benhamou PY
Diabetes Ther; 2021 Jan; 12(1):235-246. PubMed ID: 33165838
[TBL] [Abstract][Full Text] [Related]
9. The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes.
Fonda SJ; Graham C; Munakata J; Powers JM; Price D; Vigersky RA
J Diabetes Sci Technol; 2016 Jul; 10(4):898-904. PubMed ID: 26843480
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.
García-Lorenzo B; Rivero-Santana A; Vallejo-Torres L; Castilla-Rodríguez I; García-Pérez S; García-Pérez L; Perestelo-Pérez L
J Eval Clin Pract; 2018 Aug; 24(4):772-781. PubMed ID: 29971893
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.
Serné EH; Roze S; Buompensiere MI; Valentine WJ; De Portu S; de Valk HW
Adv Ther; 2022 Apr; 39(4):1844-1856. PubMed ID: 35226346
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK.
Roze S; Buompensiere MI; Ozdemir Z; de Portu S; Cohen O
J Med Econ; 2021; 24(1):883-890. PubMed ID: 34098834
[TBL] [Abstract][Full Text] [Related]
13. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
Chaugule S; Graham C
J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece.
Lambadiari V; Ozdemir Saltik AZ; de Portu S; Buompensiere MI; Kountouri A; Korakas E; Sharland H; Cohen O
Diabetes Technol Ther; 2022 May; 24(5):316-323. PubMed ID: 34962140
[No Abstract] [Full Text] [Related]
17. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran.
Molaee MC; Naseri ZG; Karami MA
Value Health Reg Issues; 2024 May; 43():101002. PubMed ID: 38820700
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
Del Prato S; Giorgino F; Szafranski K; Poon Y
Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38853717
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes.
Palmer AJ; Dinneen S; Gavin JR; Gray A; Herman WH; Karter AJ
Curr Med Res Opin; 2006 May; 22(5):861-72. PubMed ID: 16709308
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]